PharmaTimes | in-depth news, features and insights for the ...
Nov 7, 2024 · Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020.
News - PharmaTimes
Oct 31, 2024 · NICE recommends remote monitoring technology for heart failure patients. 31st Oct 2024. Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020.
Pharmaceuticals in 2022 - PharmaTimes
Dec 7, 2021 · Published in PharmaTimes magazine - December 2021. The pharma industry has been pivotal during the pandemic and this focus looks set to continue into 2022. The coronavirus pandemic has not only boosted many pharmaceutical companies’ revenues, it has also bolstered their reputations. The value of pharma innovation is undoubted, after COVID-19 ...
Global trends in clinical research - PharmaTimes
Jul 8, 2021 · Key trends from the report include: Clinical trial starts increased 8% for the full year of 2020, a similar growth as in the prior three years, and despite the significant drop in starts during the first quarter as the pandemic delayed and disrupted all parts of health systems globally. From mid-year, trial starts recovered to higher levels ...
The ecosystem overtakes the producers in pharma and life sciences
Dec 7, 2021 · Overview. This year has seen a resurgence in M&A activity in the pharma and life sciences sector after a rather anaemic entrance into the decade in 2020.
PharmaTimes - June 2021
This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory considerations on both sides of the Atlantic for starting cell and gene therapy trials (p26), while others look at the rise of genetic sequencing (p30) and 2021 trends in global trials (p20).
PharmaTimes - June 2024
This issue is about the shaping, delivery and future of clinical trials – the exciting dawn of a new era for how therapies reach the marketplace. We cover the influence of digital, the radical shift in trial design and, above all, the need to incorporate patients at every stage. We’ve also got a review of our International Clinical Researcher of the Year bash – an unforgettable 25th ...
Deal or no deal - PharmaTimes
Mar 14, 2024 · Approaches to M&As in pharma points to each company’s philosophy. According to GlobalData’s Q4 2023 update, there were 426 M&A deals announced in the global pharmaceutical industry over the year, worth a total of USD 84.2Bn.
April 2022 - PharmaTimes
PharmaTimes - April 2022. Strange days. In the past two years the battle against a faceless, merciless pandemic has raged throughout the world. Although casualties have been huge, the collective spirit of the global community, in combination with the astonishing creation of a life-affirming vaccine, has demonstrated that the forces of good are ...
Generics and biosimilars: innovation not imitation
Feb 4, 2022 · Generics and biosimilars: innovation not imitation. Published in PharmaTimes magazine - January/February 2022. The generic medicines industry is moving beyond making copies to developing patent-expired products, with new formulations, dosages and delivery methods. George Bernard Shaw might have been thinking about a higher art form than generic ...